In Brief | Cardiovascular Disease

Evaluating the Impact of antihypertensive deprescribing on cognitive function in elderly patients


Time to read: 01:30
Time to listen: 03:43

 
Published on MedED: 21 October  2024
Originally Published: 23 September 2024
Sourced: JAMA Internal Medicine
Type of article: In Brief
MedED Catalogue Reference: MCIB004

Category: Cardiovascular Disease
Cross Reference: Neurology, Gerontology

Keywords: antihypertension, cognitive decline, neruology

 
Key Takeaway
Deprescribing antihypertensive medications is linked to a reduced risk of cognitive decline in older adults, particularly those with dementia, highlighting the importance of patient-centred strategies to help preserve cognitive function and minimise potential harm.

Top

Originally published in JAMA Internal Medicine, 23 September 2024.This summary does not represent the original research, nor is it intended to replace the original research. Access the full Disclaimer Information
 


 
Understanding the effects of deprescribing antihypertensive medications in elderly patients is critical for improving patient-centred care.
 
This cohort study used a target trial emulation approach to examine the association between antihypertensive deprescribing and cognitive decline in long-term care residents aged 65 years or older. 
 
Eligible participants had stable antihypertensive medication use for at least four weeks and were classified into two groups: those who underwent deprescribing and those who remained stable on their medication. 

Deprescribing was defined as either reducing the total number of antihypertensive medications or reducing the dosage by 30% for at least two weeks. 
 
Patients were followed for up to 2 years or until death or discharge from the residential home. 

A total of 12,644 residents, with a mean age of 77.7 years and 97.4% being male (12,315), were eligible for the ITT analysis.

Similarly, 12,053 residents, also with a mean age of 77.7 years and 97.4% male (11,739), qualified for the per-protocol analysis.

 
Endpoints
The primary outcome was cognitive function, measured using the Cognitive Function Scale (CFS), which classifies cognitive status as cognitively intact, mildly impaired, moderately impaired, or severely impaired.
 

The following findings were recorded:
 
  • 12% of residents experienced worsened cognitive function, while 7.7% showed improvement.
 
  • In the deprescribing group, 10.8% experienced cognitive decline compared to 12.1% in the stable medication group.
 
  • In the per-protocol analysis, deprescribing was associated with a 12% reduction in the odds of worsening cognitive function per 12-week period (odds ratio 0.88, 95% CI) compared to those who continued their medication. 
 
  • The benefit of deprescribing was even more pronounced among residents with dementia, who experienced a 16% reduced risk of cognitive decline (odds ratio 0.84, 95% CI).
 
In conclusion, the study indicates that deprescribing antihypertensive medications is associated with a lower likelihood of cognitive decline in older adults, especially those with dementia. Further research could help clarify the balance between the risks and benefits of deprescribing to improve care for nursing home residents.
 
 
Access the original research article
Back to top

Disclaimer
This article is compiled from several resources researched and compiled by the contributor. It is in no way presented as an original work.  Every effort has been made to attribute quotes and content correctly. Where possible all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 


Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.

Rapid SSL

The Medical Education Network
Powered by eLecture, a VisualLive Solution